While many previous studies have suggested FGL2 expression by cancer cells may result in a less favourable prognosis28,30–33, we found that Fgl2 was expressed in the macrophage/monocyte and DC populations with minimal expression in the cancer (epithelial) cells (Fig. 1). Here, FGL2 is linked to cancer.